Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Lau Wai Ming DSWL Deswell Industries Inc 13D/A 61.8% 2y
Weinzierl John A BSIN Big Sky Industrial Inc. 13D/A 33.2% 2y
Peter J. Werth CING Cingulate Inc. 13D/A 15.42% 2y
GREYBROOK HEALTH INC. GBNH Greenbrook TMS Inc. Common Shares 13D/A 54.2% 2y
GIC Private Ltd RTO Rentokil Initial PLC 13G 5% 2y
MILLENNIUM MANAGEMENT LLC VERV Verve Therapeutics, Inc. Common Stock 13G 5.1% 2y
Affinity Asset Advisors, LLC NXTC NextCure, Inc. 13G 5.98% 2y
VV Manager II, LLC TECX Tectonic Therapeutic, Inc. 13D 7% 2y
Jeffrey Jagid CIRC Circle8 Group Inc 13D 7.5% 2y
NEEDHAM INVESTMENT MANAGEMENT LLC AIP Arteris, Inc. 13G 6.2% 2y
Portolan Capital Management, LLC QTRX Quanterix Corp 13G 5.01% 2y
DG Capital Management, LLC FENC Fennec Pharmaceuticals Inc. 13G 5.2% 2y
Wolter Global Investment Limited SJ Scienjoy Holding Corp 13D/A 12.1% 2y
Fund 1 Investments, LLC VRA Vera Bradley, Inc. 13D 9.8% 2y
Fund 1 Investments, LLC DXLG Destination XL Group, Inc. 13D 9.8% 2y
WHITMORE BRADFORD T SLSN Solesence, Inc. 13D/A 71.3% 2y
EIG Veteran Equity Aggregator, L.P. USAC USA Compression Partners, LP 13D/A 6.1% 2y
Leviticus Partners LP TWIN Twin Disc Inc 13G 5.17% 2y
BAKER BROS. ADVISORS LP TRDA Entrada Therapeutics, Inc. 13D/A 13.2% 2y
GIP II Blue Holding, L.P. HESM Hess Midstream LP 13D/A 34.3% 2y
clirSPV LLC CLIR ClearSign Technologies Corp 13D/A 19.99% 2y
Bellevue Capital Partners, LLC GNL Global Net Lease, Inc. 13D/A 12.8% 2y
NSV Investments I, L.P. VTYX Ventyx Biosciences, Inc. Common Stock 13D/A 10.1% 2y
Saba Capital Management, L.P. DMA Destra Multi-Alternative Fund 13D/A 14.1% 2y
Charles W. Ergen ECHO EchoStar CORP 13D/A 54% 2y
Hess Investments North Dakota LLC HESM Hess Midstream LP 13D/A 48.1% 2y
AECOM SHIM Shimmick Corp 13D/A 19.9% 2y
Insight Venture Partners X, L.P. NCNO nCino, Inc. 13D/A 22.3% 2y
MMCAP International Inc. SPC CUB Lionheart Holdings 13G 8.6% 2y
Timothy A. Springer TECX Tectonic Therapeutic, Inc. 13D 28.8% 2y
Value Base Ltd. CGNT Cognyte Software Ltd. 13D 9.41% 2y
Stanley Blend SST System1, Inc. 13D/A 14.9% 2y
Leavitt Equity Partners III, L.P. PIII P3 Health Partners Inc. 13D/A 19.6% 2y
ION Crossover Partners Ltd CTV Innovid Corp. 13G/A 7.9% 2y
REDWOOD CAPITAL MANAGEMENT, LLC BZFD BuzzFeed, Inc. 13G/A 0% 2y
ICAHN CARL C IEP Icahn Enterprises L.P. 13D/A 86.15% 2y
Energy Holding Corp TGLS Tecnoglass Holdings Inc. 13D/A 52.4% 2y
Carlyle Group Inc. QDEL QuidelOrtho Corp 13D/A 17.6% 2y
Irrevocable Larson Family Investment Trust RMTI Rockwell Medical, Inc. 13G/A 8.4% 2y
Dong-A ST Co., Ltd. MTVA MetaVia Inc. 13D/A 53.5% 2y
Venu Raman Kumar AERT Aeries Technology, Inc. 13D/A 62.13% 2y
Galkin Vladimir JBLU Jetblue Airways Corp 13G/A 5.6% 2y
ACUITAS GROUP HOLDINGS, LLC BIVI Biovie Inc. 13D/A 44.53% 2y
Sudhir Appukuttan Panikassery AERT Aeries Technology, Inc. 13D/A 11.68% 2y
Saba Capital Management, L.P. EMO ClearBridge Energy Midstream Opportunity Fund Inc. 13G/A 5.6% 2y
Bhisham Khare AERT Aeries Technology, Inc. 13D/A 8.65% 2y
Terrance McGuire TECX Tectonic Therapeutic, Inc. 13D 7.9% 2y
Y.D. More Investments Ltd DUKR DUKE Robotics Corp. 13D/A 21.3% 2y
MILLENNIUM MANAGEMENT LLC TDW Tidewater Inc 13G 0.5% 2y
Irrevocable Larson Family Investment Trust SCOR Comscore, Inc. 13G/A 6% 2y